Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
REVB Revelation Biosciences
9.100+0.720+8.59%
Close
02/03 16:00 ET
8.900-0.200-2.20%
Post Mkt Price 02/03 19:26 ET
High
9.800
Open
8.300
Turnover
1.68M
Low
8.060
Pre Close
8.380
Volume
184.48K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Revelation Biosciences Reverse Stk Split Will Be Effective as of the Morning of Feb 1 >REVB
Revelation Biosciences Reverse Stk Split Will Be Effective as of the Morning of Feb 1 >REVB
Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split Effective February 1, 2023 And Results Of Special Meeting Of Stockholders >REVB
Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split Effective February 1, 2023 and Results of Special Meeting of Stockholders
SAN DIEGO--(BUSINESS WIRE)--#biotechnews--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation") announced today that, on February 1, 2023, the Company will implement a 1-for-35 re
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersGenetic Technologies (NASDAQ:GENE) stock increased by 7.1% to $1.01 during Tuesday's after-market session. The market value of their outstanding shares is at $15.5 million. Nymox Pharmaceutical
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
Gainers Axcella Health Inc. (NASDAQ:AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue.Intelligent Bio So
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersCalyxt (NASDAQ:CLXT) stock increased by 140.3% to $0.45 during Tuesday's pre-market session. The company's market cap stands at $21.7 million. Celyad Oncology (NASDAQ:CYAD) shares increased by
Revelation Biosciences Announces Mandatory Unit Separation on January 13
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLucira Health (NASDAQ:LHDX) shares rose 29.5% to $0.51 during Friday's after-market session. Lucira Health's trading volume hit 3.7 million shares by close, accounting for 93.6% of its average
Comparing Savara (NASDAQ:SVRA) & Revelation Biosciences (OTCMKTS:REVB)
Revelation Biosciences (OTCMKTS:REVB – Get Rating) and Savara (NASDAQ:SVRA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies
Revelation Biosciences (OTCMKTS:REVB) Stock Price Down 3.4%
Revelation Biosciences, Inc. (OTCMKTS:REVB – Get Rating)'s share price was down 3.4% during mid-day trading on Wednesday .
Company Overview
More
Petra Acquisition, Inc. operates as a blank check company, which is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses. The firm targets companies in North America or Europe that are developing assets in the biotechnology, pharmaceutical, medical devices or technology, digital health, and healthcare or wellness sectors. The company was founded in 2019 and is headquartered in New York, NY.
CEO： Mr. James Rolke
Market： NASDAQ
Listing Date： 10/08/2020
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet